Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Dr. Peter Attia

👤 Speaker
11186 total appearances

Appearances Over Time

Podcast Appearances

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

When you go through the four leading causes of cancer death, two of them don't need to be on the list. Colon cancer and prostate cancer don't need to be on the list.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

When you go through the four leading causes of cancer death, two of them don't need to be on the list. Colon cancer and prostate cancer don't need to be on the list.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Now, lung, I think we can reduce it a lot, but it's going to be awfully tough. And breast is still really tough because it's not Halstedian. It doesn't have that straightforward progression from polyp to cancer. No, it's true.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Now, lung, I think we can reduce it a lot, but it's going to be awfully tough. And breast is still really tough because it's not Halstedian. It doesn't have that straightforward progression from polyp to cancer. No, it's true.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

What is your level of optimism that we could ever... So instead of just talking about a broad liquid biopsy, let's just talk about breast cancer. What do you think it would take? And do you think it would be a protein? Do you think it would be DNA? Do you think it would be RNA? If you had to guess, what would be the earliest signature in the blood of different breast cancers?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

What is your level of optimism that we could ever... So instead of just talking about a broad liquid biopsy, let's just talk about breast cancer. What do you think it would take? And do you think it would be a protein? Do you think it would be DNA? Do you think it would be RNA? If you had to guess, what would be the earliest signature in the blood of different breast cancers?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Where would you put your money?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Where would you put your money?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Think about how that would change breast cancer treatment.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Think about how that would change breast cancer treatment.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

It's funny. I say the following deliberately not acknowledging your gender because I'm sure you hear all the time, Sue, you are the most remarkable example of a woman in medicine. Gender aside, you are just a remarkable inspiration, period, as a physician, as a business leader, as a public health official. I have been a fan of yours for so long.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

It's funny. I say the following deliberately not acknowledging your gender because I'm sure you hear all the time, Sue, you are the most remarkable example of a woman in medicine. Gender aside, you are just a remarkable inspiration, period, as a physician, as a business leader, as a public health official. I have been a fan of yours for so long.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

When I walked into that room last year and saw you sitting there, I was giddy. So thank you for humoring me and making the trip possible.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

When I walked into that room last year and saw you sitting there, I was giddy. So thank you for humoring me and making the trip possible.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Thank you for listening to this week's episode of The Drive. Head over to PeterAttiaMD.com forward slash show notes if you want to dig deeper into this episode. You can also find me on YouTube, Instagram and Twitter, all with the handle PeterAttiaMD. You can also leave us a review on Apple Podcasts or whatever podcast player you use.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Thank you for listening to this week's episode of The Drive. Head over to PeterAttiaMD.com forward slash show notes if you want to dig deeper into this episode. You can also find me on YouTube, Instagram and Twitter, all with the handle PeterAttiaMD. You can also leave us a review on Apple Podcasts or whatever podcast player you use.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously.